Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology...

Oct 25, 2023

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

Press releases are necessarily short, so we like to go...

Oct 25, 2023

More news

All Article Blog Pressrelease

EnginZyme announces the appointment of new board members

Jun 01, 2021

Pressrelease

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden

Feb 11, 2021

Pressrelease

EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners

Apr 22, 2020

Pressrelease

1 2

Media contact

Karim Engelmark Cassimjee

CEO and co-founder

press@enginzyme.com

Media kit

Download images
Download presskit

Contacts

Stay up to date with our latest news

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

More news

EnginZyme announces the appointment of new board members

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden

EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners

Media contact

Karim Engelmark Cassimjee

Media kit

About

Products and services

Contact

Contacts

Stay up to date with our latest news

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

More news

EnginZyme announces the appointment of new board members

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden

EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners

Media contact

Karim Engelmark Cassimjee

Media kit

Stay in touch with us. Sign up here for EnginZyme Insights.

Thanks for signing up!

Could not submit form.

Stay in touch with us.
Sign up here for EnginZyme Insights.